Physician profile
Thomas Damato
NPI 1073544235
$8,209.37
in general payments reported to CMS, 2019-2025
19 companies · $23.44 in 2025
The $23.44 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,021 · 2020: $1,251 · 2021: $478 · 2022: $1,083 · 2023: $627 · 2024: $726 · 2025: $23.44.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,377.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,376.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $2,502.45 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $2,196.44 | 2019-2022 | |
| Abiomed | $816.91 | 2019-2024 | Impella |
| Medtronic, INC. | $595.15 | 2021-2025 | Penditure, Avalus, Freestyle |
| Atricure, INC. | $463.82 | 2019-2023 | |
| Getinge USA Sales, LLC | $370.95 | 2019-2024 | Acrobat-I Stabilizer, Vasoview Hemopro 2 |
| Edwards Lifesciences Corporation | $328.17 | 2021-2024 | Sapien 3 Ultra Resilia |
| Bolton Medical INC | $300.25 | 2022 | |
| Ethicon US, LLC | $147.76 | 2023-2024 | Stratafix, Prolene, Vistaseal |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $118.54 | 2019-2023 | Lifevest |
| Kci USA, INC. | $91.73 | 2023 | Prevena, 3m Skin and Nasal Antiseptic |
| Pinnacle Biologics, INC | $84.19 | 2019 | |
| Indivior INC. | $56.77 | 2019 | |
| Baxter Healthcare | $49.95 | 2022 | |
| Kls-Martin L.P. | $24.72 | 2019-2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $17.77 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $14.98 | 2023 | Farxiga |
| Siemens Medical Solutions USA, INC. | $14.53 | 2024 | Somatom X.Cite |
| Chiesi USA, INC. | $14.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Damato listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.